Feedback / Questions
deupirfenidone (LYT-100) - PureTech
https://www.businesswire.com/news/home/20260219184180/en/PureTech-Announces-Orphan-Drug-Designations-Granted-by-the-U.S.-Food-and-Drug-Administration-and-European-Commission-for-Deupirfenidone-LYT-100-in-Idiopathic-Pulmonary-Fibrosis
Feb 19, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next